Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats

Hepatology

Volumn 28, Issue 3, 1998, Pages 756-760

  Kaido, Toshimi ^a   Yoshikawa, Akira ^a   Seto, Shin Ichi ^a   Yamaoka, Shoji ^a   Sato, Maki ^b   Ishii, Takehisa ^b   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT SCATTER FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; GROWTH STIMULATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER REGENERATION; LIVER RESECTION; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; TREATMENT INDICATION; TREATMENT OUTCOME; VEIN LIGATION;

EID: 0031752379     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280323     Document Type: Article

References (22)

1. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopalhologic features and results of surgical treatment. Ann Surg 1990;211:277-287.
2. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection: a study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 1987;206:30-39.
3. Rous P, Larimore LD. Relation of the portal blood to liver maintenance; a demonstration of liver atrophy conditional on compensation. J Exp Med 1920;31:609-632.
4. Ozawa K, Takasan H, Kitamura O, Mizukami T, Kamano T. Effect of ligation of portal vein in liver mitocnondrial metabolism. J Biochem 1971;70:755-764.
5. Honjo I, Suzuki T, Ozawa K, Takasan H, Kitamura O, Ishikawa T. Ligation of a branch of the portal vein for carcinoma of the liver. Am J Surg 1975;130:296-302.
6. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986;10:803-808.
7. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, Yamazaki S, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990;107:521-527.
8. Kawasaki S, Makuuchi M, Kakazu T, Miyagawa S, Takayama T, Kosuge T, Sugihara K, et al. Resection for multiple metastatic liver tumors after portal embolization. Surgery 1994;115:674-677.
9. Kutsuma Y, Hayakawa N, Yamamoto H. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery 1995;117:677-687.
10. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration and other biological functions. Crit Rev Oncog 1992;3:27-54.
11. Rubin JS, Bottaro DP, Aaronson SA. Hepatocyte growth factor/scatter factor and its receptor, the c-met protooncogene product. Biochim Biophy Acta 1993;1155:357-371.
12. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984;122:1450-1459.
13. Russell WE, McGowan JA, Bucher NL. Partial characterization of a hepatocyte growth factor from rat platelets. J Cell Physiol 1984;119:183-192.
14. Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, Tomiya T, et al. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. HEPATOLOGY 1993;18:1443-1449.
15. Shiota G, Wang TC, Nakamura T, Schmidt EV. Hepatocyte Growth Factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. HEPATOLOGY 1994;19:962-972.
16. Sakata H, Takayama H, Sharp R, Rubin JS, Merlino G, LaRochelle WJ. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ 1996;7:1513-1523.
17. Ishii T, Sato M, Sudo K, Suzuki M, Nakai H, Hishida T, Niwa T, et al. Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepateclomized rats. J Biochem Tokyo 1995;117:1105-1112.
18. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent anti-hepatitis effect in vivo. HEPATOLOGY 1992;16:1227-1235.
19. 4-induced acute liver injury in rats. Biochem Biophys Res Commun 1996;218:1-5.
20. Kaido T, Yamaoka S, Seto S, Tanaka J, Funaki N, Nakamura T, Imamura M. Continuous hepatocyte growth factor supply prevents lipopolysaccharide-induced liver injury in rats. FEES Lett 1997;411:378-382.
21. Matsuda Y, Matsumoto K, Ichida T, Nakamura T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem Tokyo 1995;118:643-649.
22. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Antifibrotic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. HEPATOLOGY 1996;24:636-642.